|
Volumn 9, Issue 1, 2002, Pages 63-68
|
Complications of ultrarapid opioid detoxification with subcutaneous naltrexone pellets
a a a a a |
Author keywords
Addiction; Detoxification; Heroin; Naltrexone; Opioids; Rapid detoxification; Ultrarapid detoxification
|
Indexed keywords
ALPRAZOLAM;
CLONIDINE;
DIAMORPHINE;
DIPHENHYDRAMINE;
FLUOXETINE;
FUROSEMIDE;
GLYCERYL TRINITRATE;
LORAZEPAM;
METHADONE;
NALTREXOL;
NALTREXONE;
ONDANSETRON;
OPIATE AGONIST;
PARACETAMOL;
PHENOBARBITAL;
TRAZODONE;
ZOLPIDEM;
ADULT;
ARTICLE;
ASPIRATION PNEUMONIA;
BLOOD VESSEL RUPTURE;
CLINICAL ARTICLE;
CLINICAL FEATURE;
DEATH;
DIARRHEA;
DRUG IMPLANTATION;
DRUG WITHDRAWAL;
DYSPNEA;
FATIGUE;
FEMALE;
HUMAN;
LUNG EDEMA;
MALE;
MUSCLE WEAKNESS;
OLIGURIA;
OPIATE ADDICTION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
VOMITING;
WITHDRAWAL SYNDROME;
XEROSTOMIA;
ADMINISTRATION, CUTANEOUS;
ADULT;
DELAYED-ACTION PREPARATIONS;
DRUG IMPLANTS;
EMERGENCY TREATMENT;
EPILEPSY, TONIC-CLONIC;
FATAL OUTCOME;
FEMALE;
HUMANS;
MALE;
NALTREXONE;
NARCOTIC ANTAGONISTS;
OPIOID-RELATED DISORDERS;
PULMONARY EDEMA;
RISK ASSESSMENT;
SUBSTANCE WITHDRAWAL SYNDROME;
TIME FACTORS;
UNCONSCIOUSNESS;
VOMITING;
|
EID: 0036140773
PISSN: 10696563
EISSN: None
Source Type: Journal
DOI: 10.1197/aemj.9.1.63 Document Type: Article |
Times cited : (50)
|
References (25)
|